Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Giuliano, Barthes Am, B. Spivack, Beitsch Pd, Evans Sw (1996)
Incidence and predictors of axillary metastasis in T1 carcinoma of the breast.Journal of the American College of Surgeons, 183 3
J. Albertini, G. Lyman, Charles Cox, T. Yeatman, L. Balducci, N. Ku, S. Shivers, C. Berman, K. Wells, D. Rapaport, A. Shons, J. Horton, H. Greenberg, S. Nicosia, R. Clark, A. Cantor, D. Reintgen (1996)
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.JAMA, 276 22
D. Krag, D. Weaver, T. Ashikaga, F. Moffat, V. Klimberg, C. Shriver, S. Feldman, R. Kusminsky, M. Gadd, J. Kuhn, S. Harlow, P. Beitsch (1999)
The sentinel node in breast cancerplastic Surgical Nursing, 19
AE Giuliano, DM Kirgan, JM Guenther, DL Morton (1994)
Lymphatic mapping and sentinel lymphadenectomy for breast cancerAnn Surg, 220
(1998)
Sentinel lymph node biopsy in breast cancer: the initial experience at Memorial SloanKettering Cancer Center
D. Krag, D. Weaver, James Alex, J. Fairbank (1993)
Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surgical oncology, 2 6
D Krag, D Weaver, T Ashikaga (1998)
Sentinel node in breast cancerN Engl J Med, 339
P. Rosen, S. Groshen, P. Saigo, D. Kinne, S. Hellman (1989)
Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 7 9
K. Smitten (2001)
Sentinel node in breast cancerEuropean Journal of Cancer, 37
D. Morton, Wenger Dr, J. Wong, J. Economou, L. Cagle, Storm Fk, L. Foshag, A. Cochran (1992)
Technical details of intraoperative lymphatic mapping for early stage melanoma.Archives of surgery, 127 4
D. Ivens, A. Hoe, T. Podd, C. Hamilton, I. Taylor, G Royle (1993)
EPA Reevaluation of Dioxin's RisksEnvironmental Health Perspectives, 101
D Ivens, AL Hoe, TJ Podd, CR Hamilton, I Taylor, GT Royle (1992)
Assessment of morbidity from complete axillary dissectionBr J Cancer, 66
(2013)
Sentinel lymph node biopsy for breast cancer.Clinical privilege white paper, 82
U. Veronesi, G. Paganelli, V. Galimberti, G. Viale, S. Zurrida, M. Bedoni, Alberto Costa, C. Cicco, J. Geraghty, A. Luini, V. Sacchini, P. Veronesi (1997)
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 349
M. Kissin, G. Querci, della Roveret, D. Easton, G. Westbury, M. Kissin (1986)
Risk of lymphoedema following the treatment of breast cancerBritish Journal of Surgery, 73
A. Giuliano, Ralph Jones, M. Brennan, R. Statman (1997)
Sentinel lymphadenectomy in breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 6
A. Hill, K. Tran, T. Akhurst, H. Yeung, S. Yeh, P. Rosen, P. Borgen, H. Cody (1999)
Lessons learned from 500 cases of lymphatic mapping for breast cancer.Annals of surgery, 229 4
M. Kelley, N. Hansen, K. McMasters (2004)
Lymphatic mapping and sentinel lymphadenectomy for breast cancer.American journal of surgery, 188 1
(1996)
Lymphatic mapping and SLNB in the patient with breast cancer
P. Rosen, M. Lesser, D. Kinne, E. Beattie (1983)
Discontinuous or “Skip” Metastases in Breast Carcinomae: Analysis of 1228 Axillary DissectionsAnnals of Surgery, 197
D. Krag, D. Weaver, T. Ashikaga, F. Moffat, V. Klimberg, C. Shriver, S. Feldman, R. Kusminsky, M. Gadd, J. Kuhn, S. Harlow, P. Beitsch, Pat Whitworth, R. Foster, K. Dowlatshahi (1998)
The sentinel node in breast cancer--a multicenter validation study.The New England journal of medicine, 339 14
D. Reintgen, J. Albertini, G. Milliotes, J. Marshburn, C. Cruse, D. Rapaport, C. Berman, F. Glass, N. Fensske, A. Einstein, G. Lyman (1997)
Investment in new technology research can save future health care dollars.The Journal of the Florida Medical Association, 84 3
Background: The introduction of SLNB has allowed accurate staging in early-stage breast carcinomas and has minimized the number of unnecessary ALNDs. Intraoperative frozen-section analysis is a fundamental component of the sentinel lymph node biopsy (SLNB) procedure. Some patients have positive nodes on frozen-section analysis and thus undergo a conventional axillary lymph node dissection (ALND) at the time of the SLNB. A few patients have negative nodes on frozen-section analysis but have subsequent evidence of metastases on final pathologic examination. The purpose of our study was 2-fold: to compare the hospital-related charges of patients undergoing staging by SLNB with those of patients undergoing conventional ALND and to assess whether the different outcomes associated with SLNB adversely affect the charges incurred with this procedure.
Annals of Surgical Oncology – Springer Journals
Published: Oct 16, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.